
Vaccine distribution inequalities and their effects on Kenyans
The Covid-19 has been with us for over a year, since the first case was reported in the country in the first quarter of 2020. Even though members of the public still have to adhere [c]
The Covid-19 has been with us for over a year, since the first case was reported in the country in the first quarter of 2020. Even though members of the public still have to adhere [c]
In an era of self-isolation and restrictions, consumers are paying more attention to their health and personal safety while dating, according to a new report commissioned by Kaspersky. Four-in-10 (42%) globally prefer to only meet [c]
The beginning of the year is always a sound time to review the main developments and incidents that took place in the cybersecurity industry over the past year. To look at the impact these events [c]
In the autumn of 2020 (for the northern hemisphere), Kaspersky researchers identified two APT incidents that targeted entities related to COVID-19 research – a Ministry of Health body and a pharmaceutical company. Kaspersky experts assessed [c]
Pfizer and BioNTech announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a [c]
Copyright 2023 | aptantech